LINC01287

Across TCGA pan-cancer cohorts, LINC01287 RNA differs between tumor and matched normal tissue in 6 of 18 cancer types tested, making tumor–normal expression one of LINC01287’s most consistent transcriptional readouts.

The strongest signal is observed in thyroid carcinoma (THCA), where LINC01287 RNA is repressed in tumor relative to normal tissue. In most cancer types LINC01287 is over-expressed in tumor, although a few such as THCA and BRCA show the opposite, repressed pattern.

THCA, LIHC, and READ are the cancer types where LINC01287 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in LINC01287 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
THCA	All	All	−0.029	.003	6	view →
LIHC	All	All	+1.351	<.001	5	view →
READ	All	All	+0.070	.005	5	view →
COAD	All	All	+0.042	.004	3	view →
CHOL	All	All	+0.123	.010	2	view →
BRCA	All	III,IV	−0.120	.010	2	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 6 strongest of 6 lineages.

LINC01287–THCA

Open the THCA breakdown →